openPR Logo
Press release

Postoperative Pain Management Market is expected to Hit US$ 65.36 Billion by 2033 | Major Companies - Pacira Pharmaceuticals, Inc., Heron Therapeutics, Inc., Johnson & Johnson, Virpax Pharmaceuticals

02-26-2026 06:14 AM CET | Health & Medicine

Press release from: DataM Intelligence 4Market Research

Postoperative Pain Management Market

Postoperative Pain Management Market

Market Size and Growth:

The Global Postoperative Pain Management Market size reached US$ 41.17 Billion in 2024 from US$ 39.26 Billion in 2023 and is expected to reach US$ 65.36 Billion by 2033, growing at a CAGR of 5.4% during the forecast period 2025-2033.

DataM Intelligence has published a new research report on "Postoperative Pain Management Market Size 2026". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/postoperative-pain-management-market?sz

The Postoperative Pain Management Market refers to the global industry focused on products, therapies, and services used to reduce and control pain following surgical procedures. It includes pharmaceuticals such as opioids, non-opioid analgesics, local anesthetics, and advanced drug delivery systems, along with non-pharmacological pain relief technologies. The market aims to improve patient recovery outcomes, shorten hospital stays, and enhance comfort through effective pain control strategies across hospitals, ambulatory surgical centers, and home care settings worldwide.

Recent Key Developments of United States:

✅ February 2026: Updated guidelines from the American Society of Anesthesiologists emphasized peripheral nerve blocks, correlating with a 15% drop in hospital readmissions for pain-related issues.

✅ January 2026: Leading hospitals implemented non-opioid neuromodulation devices, following positive Phase III results for transcutaneous electrical nerve stimulation in orthopedic surgeries.

✅ December 2025: A major clinical trial validated AI-driven pain assessment tools, improving real-time postoperative monitoring and reducing opioid prescriptions by 20% in pilot hospitals. Telemedicine integration for pain follow-up expanded nationwide.

✅ November 2025: The FDA approved a new extended-release opioid formulation for postoperative use, enhancing patient-controlled analgesia with reduced dosing frequency. Multimodal protocols integrating NSAIDs and regional anesthesia gained wider adoption in ambulatory surgery centers.

Recent Key Developments of Japan:

✅ February 2026: R&D investments surged in oncology-related pain management, supported by "Society 5.0" initiatives for tech-enabled recovery in over 1.5 million annual surgeries.

✅ January 2026: AI innovations in personalized analgesics boosted sector growth amid regulatory advancements.

✅ December 2025: Market reports highlighted rising minimally invasive surgery integration with digital pain tools.

List of the Key Players in the Postoperative Pain Management Market:

Pacira Pharmaceuticals, Inc.
Heron Therapeutics, Inc.
Mallinckrodt Pharmaceuticals
Johnson & Johnson
Vertex Pharmaceuticals Incorporated
Virpax Pharmaceuticals
Grünenthal
Oakwood Labs

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/postoperative-pain-management-market?sz

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Segments Covered in the Postoperative Pain Management Market:

By Drug Type: Opioids, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Local Anesthetics, Cyclooxygenase-2 (COX-2) Inhibitors, and Others.

By Route of Administration: Injectable, Oral, Topical, and Others.

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=postoperative-pain-management-market

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: key insights, key emerging trends, etc.

Chapter 3: Manufacturers competitive analysis, detailed analysis of Postoperative Pain Management manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 5 & 6: Revenue of Postoperative Pain Management in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: The main points and conclusions of the report.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Postoperative Pain Management Market in 2026?
◆ What is the projected growth rate of the Postoperative Pain Management Market through 2034?
◆ Who are the key players in the Postoperative Pain Management Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Postoperative Pain Management Market is expected to Hit US$ 65.36 Billion by 2033 | Major Companies - Pacira Pharmaceuticals, Inc., Heron Therapeutics, Inc., Johnson & Johnson, Virpax Pharmaceuticals here

News-ID: 4405583 • Views:

More Releases from DataM Intelligence 4Market Research

Infectious Diseases Treatment Market is expected to Hit US$ 264.75 Billion by 2033 | Major Companies - Pfizer Inc., AbbVie, Gilead Sciences, Inc., Merck & Co., Inc.
Infectious Diseases Treatment Market is expected to Hit US$ 264.75 Billion by 20 …
Market Size and Growth: The Global Infectious Diseases Treatment Market size reached US$ 189.09 Billion in 2024 from US$ 182.65 Billion in 2023 and is expected to reach US$ 264.75 Billion by 2033, growing at a CAGR of 3.9% during the forecast period 2025-2033. DataM Intelligence has published a new research report on "Infectious Diseases Treatment Market Size 2026". The report explores comprehensive and insightful Information about various key factors like Regional
Ophthalmology Drugs Market is expected to reach US$ 73.97 Billion by 2033 | Major Companies - F. Hoffmann-La Roche, Merck & Co., Inc., Pfizer Inc., Novartis AG
Ophthalmology Drugs Market is expected to reach US$ 73.97 Billion by 2033 | Majo …
Market Size and Growth: The Global Ophthalmology Drugs Market size reached US$ 42.30 Billion with a rise of US$ 44.58 Billion in 2024 and is expected to reach US$ 73.97 Billion by 2033, growing at a CAGR of 5.8% during the forecast period 2025-2033. DataM Intelligence has published a new research report on "Ophthalmology Drugs Market Size 2026". The report explores comprehensive and insightful Information about various key factors like Regional Growth,
Neurotherapeutics Market is expected to Hit US$ 11.10 Billion by 2033 | Major Companies - Medtronic, Boston Scientific Corporation, Abbott, Aleva Neurotherapeutics
Neurotherapeutics Market is expected to Hit US$ 11.10 Billion by 2033 | Major Co …
Market Size and Growth: The Global Neurotherapeutics Market size reached US$ 7.28 Billion in 2024 from US$ 6.97 Billion in 2023 and is expected to reach US$ 11.10 Billion by 2033, growing at a CAGR of 4.9%during the forecast period 2025-2033. DataM Intelligence has published a new research report on "Neurotherapeutics Market Size 2026". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue
United Kingdom Brain Supplements Market is expected to Hit US$ 2.87 billion by 2032 | Major Companies - G. Baldwin & Co., Boots, WeightWorld, Teva Pharmaceutical Industries Ltd.
United Kingdom Brain Supplements Market is expected to Hit US$ 2.87 billion by 2 …
Market Size and Growth: The UK Brain Supplements Market size reached US$ 0.96 billion in 2024 and is expected to reach US$ 2.87 billion by 2032, growing with a CAGR of 14.66% during the forecast period 2025-2032. DataM Intelligence has published a new research report on "UK Brain Supplements Market Size 2026". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of

All 5 Releases


More Releases for Postoperative

Postoperative Acute Pain Market Trends, Treatments, and Global Forecast
Postoperative acute pain (POAP) remains one of the most significant challenges in clinical care, affecting nearly 80% of patients after surgery. Poorly managed pain can lead to complications such as delayed recovery, prolonged hospital stays, readmissions, and higher healthcare costs. Traditionally, opioid analgesics have been the cornerstone of treatment, but rising concerns around opioid dependency and adverse effects are fueling demand for safer, multimodal pain management approaches. Download Full PDF Sample
Postoperative Pain Therapeutics Market Innovations and Trends for 2032
The Postoperative Pain Therapeutics market has become an essential sector within the healthcare industry, particularly in the wake of increasing surgical procedures and the subsequent need for effective pain management solutions. This market encompasses a wide range of therapeutics designed to alleviate pain following surgical interventions, ensuring patient comfort and satisfaction during recovery. With a focus on improving patient outcomes, the postoperative pain therapeutics market has seen significant advancements, driven
Postoperative Pain Therapeutics Market Analysis and Forecast (2024-2032)
The introduction serves as the foundational section of our analysis. It aims to provide a comprehensive overview of the Postoperative Pain Therapeutics Market, emphasizing its significance and the purpose of the analysis. The Postoperative Pain Therapeutics Market plays a pivotal role in the healthcare industry. It addresses the critical need for effective pain management following surgical procedures, contributing to patient comfort and recovery. This market has witnessed substantial growth due to
Postoperative Pain Therapeutics Market: An In-Depth Analysis
In the ever-evolving landscape of healthcare, the Postoperative Pain Therapeutics Market has emerged as a significant player. This market, valued at USD 0.88 billion in 2023, is driven by various factors such as the production and commercialization of new drugs, increased research and development activities, rising health concerns, enhanced diagnostics facilities, and a growing global population. With a projected compound annual growth rate (CAGR) of 9.3% between 2024 and 2032,
Postoperative Nausea and Vomiting Management Market Rising focus on patient comf …
Global Postoperative Nausea and Vomiting Management Market Overview: The Postoperative Nausea and Vomiting Management market is a broad category that includes a wide range of products and services related to various industries. This market comprises companies that operate in areas such as consumer goods, technology, healthcare, and finance, among others. In recent years, the Postoperative Nausea and Vomiting Management market has experienced significant growth, driven by factors such as increasing consumer demand,
Prevention and management of postoperative endophthalmitis
The decisive criterion of postoperative endophthalmitis after cataract operations or intravitreal injections is the contamination of the operating area and the instruments / implants with pathogens during the surgical procedure. In traditional operating theaters, the "sterility" is very limited and only given directly under the supply air ceiling. However, the surgical field is almost completely shielded from the ultra-clean air by the surgical microscope and the surgeon's head, so that